Home
About
Overview
Sharing Data
ORCID
Help
History (31)
The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.
Hepatitis B Vaccines
Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT.
Engineering the nanoparticle-protein interface: applications and possibilities.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Engineering the nanoparticle-protein interface: applications and possibilities.
Rana S, Yeh YC, Rotello VM. Engineering the nanoparticle-protein interface: applications and possibilities. Curr Opin Chem Biol. 2010 Dec; 14(6):828-34.
View in:
PubMed
subject areas
Animals
Humans
Nanoparticles
Proteins
Surface Properties
authors with profiles
Vincent Rotello PhD